Main Library
The CMS estimates terminating the models will save nearly $750 million. The agency will also no longer implement two demonstrations that aimed to improve prescription drug affordability and access.
Dive Brief:
- The CMS Innovation Center is canceling four payment models early and halting two demonstrations before they begin, the agency said Wednesday, in the Trump administration’s latest rollback of federal spending in healthcare.
- Four models — Maryland Total Cost of Care, Primary Care First, End-Stage Renal Disease Treatment Choices and Making Care Primary — will end by Dec. 31, according to a news release. The CMS estimates terminating the programs early will save nearly $750 million, though regulators did not quantify where those savings will come from.
- The CMMI will also no longer implement the Medicare $2 Drug List and the Accelerating Clinical Evidence demonstration after President Donald Trump revoked a Biden-era executive order that ordered the agency to consider new models to limit drug spending.